GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kane Biotech Inc (OTCPK:KNBIF) » Definitions » Cash Flow for Lease Financing

KNBIF (Kane Biotech) Cash Flow for Lease Financing : $0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Kane Biotech Cash Flow for Lease Financing?

Kane Biotech's Cash Flow for Lease Financing for the three months ended in Dec. 2024 was $0.00 Mil. Kane Biotech's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Sep. 2024 ), Kane Biotech's Cash Flow for Lease Financing remained the same in Dec. 2024 ($0.00 Mil).

Kane Biotech Cash Flow for Lease Financing Historical Data

The historical data trend for Kane Biotech's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kane Biotech Cash Flow for Lease Financing Chart

Kane Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Kane Biotech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kane Biotech Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Kane Biotech's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Kane Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kane Biotech Inc (OTCPK:KNBIF) » Definitions » Cash Flow for Lease Financing
Comparable Companies
XCNQ:GLOW TSXV:RKV TSXV:IBO TSXV:CYTO XCNQ:BIOV TSX:APS TSXV:QPT TSXV:IOT XCNQ:ASEP XCNQ:BLAB VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
KNE:Canada
Address
290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Website
https://www.kanebiotech.com
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.